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Nitric oxide is a potent mediator of endotheliunl-
dependent vasodilatation, the synthesis of which is 
catalyzed by the constitutively expressed enzynte 
endothelial nitric oxide synthase. In this study we 
have investigated whether human dermal Inicrovas-
cular endothelial cells express endothelial nitric ox-
ide synthase and whether the vasodilator neuropep-
tides, calcitonin gene-related peptide and substance 
P, stimulate the release of nitric oxide frOln these 
cells. Endothelial nitric oxide synthase was identified 
by immunohistochemistry ill. the blood vessels in 
both the papillary and deep dermis of normal skin, 
and also in nlonolayers of human dermal microvas-
cular endothelial cells. 011. western blots of protein 
extracts prepared from both the dermis of normal 
h UDlan skin and hUlnan dermal nlicrovascular endo-
thelial cells, a 135-kba band corresponding to endo-
thelial nitric oxide synthase was identified. Nitric 
oxide was released from unstiInulated human dennal 
microvascular endothelial cells as assessed by inhibi-
tion of platelet aggregation and nitrite formation. 
T h ere is n ow substantia l evidence to indicate that vasodilator Il e uropeptides a re ,lc tive ly in volved in the main ten ance of vascular tone ill th e pe ripheral cir-culation (B unker et (/1, 1990). In human skin , the capillaries of the microvasculature li e in proxi mi ty 
to peptidergic nerves th a t are ri ch in calcitonin gene-re lated pep-
tide (CGRP) and also contain substan ce P (SP) (Bloom and Polak, 
1983). Both o f these peptides are potent vasod ilators fo llowing 
intradermal injec tio n in to hum an skin (Foreman , 1987) . SP indu ces 
a classic whorl and Am'e response by acting directly on the skin 
microvasculature and also on mast cells to release histamine, which 
in turn acts on the mic rovasculatu re (Foreman, J 987). JJI contras t, 
CGRP induces a characteri stic e ryth ema (Brain eI (/1, 1985), w hich 
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A bbrcviations: CG R .. P, calcitonin gene-relatcd peptide; SP, substance P; 
NO, nitric oxidc; NOS , ni tric oxide synthase; eNOS. endothelial nitric 
oxide synthase; L-NAM E. N'-'-ni tro-L-arginine mcthyl cster; I.-NMM A, 
W -monolTl cthyl-L-arginine; HE. hOl11 ogenizing buffer; CHA PS, 3-[3-chol-
amidopropyl)dil11cthylal11l11onioJ-l -propancsulphonate; I-Ib , hemoglobin; 
SEM , standard error of the mean. 
Endothelial cell-m.ediated inhibition of platelet ag-
gregation was blocked by hemoglobin, which binds 
nitric oxide. Substance P (10 nM) potentiated micro-
vascular endothelial cell inhibition of platelet aggre-
gation, and this effect was also blocked by hemoglo-
bin. Calcitonin gene-related peptide (100 pM to 100 
nM) directly inhibited platelet aggregation, and this 
direct effect was not modulated by microvascular 
endothelial cells. Substance P (10 nM to 1 J.tM) and 
calcitonin gene-related peptide (100 pM to 10 nM) 
significantly (p < 0.05) increased nitrite formation, 
and this increase was blocked b y the competitive 
nitric oxide synthase antagonist, W -monomethyl-L-
arginine. These results demonstrate that endothelial 
nitric oxide synthase is expressed in the microvascu-
lar endothelium of normal human skin and that 
human dermal microvascular endothelial cells re-
lease nitric oxide constitutively and in response to 
vasodilator neuropeptides. KeJI 1V00'ds: caicitollitt gelle-
rela.ted peptidel.mb.~ta.nce PIII;tvic o:dde sJ",tllaselltlllllall ski". 
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is n e ith er n eurogeni c n o r m ediated by th e l'elease of hi sta mine from 
m ast cell s (Piotrowski and Foreman , 1985), indicating that CGRP 
probably acts directly o n the microvasculatllre. 
Endothelial-dependent vasodilatation of large blood vessels and 
res istance vessels is m edia ted , at least in part, by nitri c oxide (NO) 
(Palmer ct. (/1, 1987) . N O is a rad ical that is syn thes ized from th e 
termina l g uanidino g roup of L-Hginine and reacts readily witb 
o xygen to fo rm nitrite (Henry el (/1, 1991). T he con version of 
L-arginine to N O is catalyzed b y the enzym e nitric oxide synthase 
(NOS) (Sessa, 1994); and th ree iso form s of NOS ha ve been 
identified , including a constitlltively expressed endothelial cell 
NOS (e NOS) OallSsens el (/1, 1992) . As well as be ing a potent 
vasodilato r, NO also inhibi ts plate le t adh esion and aggregation 
(Furlong el (/1, 1987). 
SP-induced vasodi latatio n in large r blood vesse ls is cndothe liut11-
dependent (Furchgott and Van l~outte, 1989) , and SP induces 
release o f NO fi'o m cultured porc ine aortic e ndotheli al cells (Smith 
and Lang, 1990). It is not known , however, ifSP indu ces re lease of 
NO frol11 th e human cutaneous mic rovascular endothe lium . 
In rat skin , the vasodilator respon se to CGRP is independen t of 
NO (Ra le vic et (/1, 1992). T his is in contrast to studies in human skin 
that indicllCe that CGIU'-induced vasodi lation is at least partially 
m ediated by NO beClmse th e N OS antagonists, W -nitro-L- argi-
nin e meth yl ester (L-NAME) and W -monomethyl-L-arginine (1..-
NMMA). reduced both the area of CGRP-indu ced ecyth e l1la and 
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CGRP-induced inc rease in skin bl ood fl o w (Goldsmi th ci 11/, in 
prcss) . 
T h e a im of th e present study h as been to d c t c rmine w h e thc r the 
e n zym e eN OS is p rcsent in huma n d erm al mi crov,lscular e ndoth c -
lium, a nd if so, whe the r t h e v asodila to r n e uro p e p ti d es CGRP a nd 
SP can stimula te re lease o f N O fi'om human d c rmal mi cr ovascular 
e ndo the li al cell s (HDMEC). For th cse exp e rimen ts, inhibitio n o f 
pla te le t aggregatio n and nitrite fo rma tion h a v e b een u sed to assess 
NO re lease . 
MATERIALS AND M ETH ODS 
Mic r o vasc ular Endothelial C e ll Cultures H D M EC we re isolated 
frol\1 neonatal fo reskin ob ta ined after ro u tine circumcisio n and established 
in cul ture as previo usly described (Bull rt 111. '1990). Confluent m on o layers 
of ce ll s between passages 2 and 5 we re used for th ese cxperinu:l1ts and th e 
cells were cul tured in the absence of 1-llIethyl-3-isobu tylxanthin c an d 
dibu tyryl cycl ic AM P fo r 24 h before each ex perim cnt. 
Immunohistochemistry f res hl y excised neona tal fo resk.in w as cu t into 
S-mm 2 pieces and snap-frozen in liquid nitrogen . IS- (.Lm cryosta t skin 
sections were cut, taken up onto 3-aminopropyltrieth oxysilane-rreated g lass 
microscope slides . and air- dri ed fo r 30 min. For immuno histochemistry, 
skin sectio ns we re fi xed in aceton e fo r 15 rnin and th e n rinsed in 
phosphate-buffered saline (PBS; 150 mM N aCl, 50 mM Na 2HPO .
" 
pH 7.4). 
H D MEC wcre rinsed w ith serum- fi'ee cul ture medium an d then fi xed in 
parafonna ldehyde (1 % (w/v) in PBS) fo r 20 min . T hey WCrc thcn rinsed in 
PBS and pcrm cabilizcd by incubating in methano l fo r 20 min. 
lmmuno h.istoche mistry was performed as described (Po llock el 111. '1993; 
Shu and Fan . 1988) using a rabbit po lyc\onal anti- eNOS an tiserum (Trans-
du cti on La bora to ries, Lexington, KY) dilu ted 1 :500 in PBS con ta ining 1% 
bovine serum albumin and a polyc\onal an ri-von W iJlebrand Factor (vWF) 
protein antiserum (Dako Ltd , High Wycombe . U .K.) d ilu ted 1:5,000 in 
PBS conra ining .\ 'Yo. bovinc serum albumin . Photomicrographs we re taken 
o n Pan I' fi lm (llfo rd . U .K.) using a Nikon (Tclfo rd, U .K.) microscope. 
NOS Isolation Samplcs of neunaml foreskin (approximately '1 gram) werc 
immersed lo r 10 min in 0 .1 5 M NaC I prehea ted to 65°C and th en transfcrred 
to 0. 15 M NaCI on icc. T he epidennis w as peeled fro m the dennis with sterile 
forceps, and separnted epidel11lal sheets 'Illd dermal sections were minced with 
fine surgical scissors in 500 fJ.1 of icc-co ld ho mogenizing buffe r (HE; 50 m M 
T ris H C I, pH 7.4 . 0.1 mM cthylened iamine tctrancetic acid. 0:1 mM ethyl-
cncglycol- bis(!3-a lllinoethyl edlcr)-N,N,N' ,N' -terraacetic acid contallung 
\ m M phenyl-mcdl yl-sulphonyl-fluoride, 20 (.LM Icupeptin , and 20 mM 
3-[3-cho lamidopropyl)dimethylammonio ]- I-propancsulphona te (C HA PS) . 
T he sarnplcs of nlinccd dennis and cpidcnnis were thcn ho mogenized 0 11 icc 
using a glass ho mogenizer w ith a Tefl on plunger. 
H D MEC. grown in 2S_cm 2 cul tu re fla sks. we re was hed brieRy in 
se rum-free lscove' s Dulbecco's modi flcd Engle ' s mediulll and overl aid w ith 
500 /1,1 of icc-cold HB. T h e cells were scraped fro m th e botto m of th e 
culture Aask and transferred to a steril e microfuge tu be. The H D MEC were 
lysed by immersio n in an ul t ra soni c bath (50 H z) fo r 30 sec. Sam ples of 
hom ogeni zed dermis and epidenni s and lysed HDM EC were mixed o n a 
rotary mixer for 30 min at 4°C and then cen trifuged ('I O .OOOc~. 20 min . 4°C). 
T hc supc rn atant was decanted and applied to a 200-(.L1 column of pre-
sw o llen adenos ine 2' ,5' - b isphospha te (2' ,5' - AD P)-aga rose. T he co lu llln 
Was washed three times with 25 iJ.1 of H13 cOlw lining 10 m M C J-l APS, and 
the N OS w as e lu ted w ith 10 mM !3-ni cotinall1ide adenine dinucleotide 
phosphatc. reduced for m ({3- NAD I'H) in 25 (.LI of H n con taining C H APS 
(Po llock <'f 111, 1991). 
E lectr ophoresis and Immullobiotting T he eluan t frolll the ADP-
agarose co lumn was solubilized in a sa mple buffe r (90 IllM T ris-H C I. pH 
6 .8, 1 'y" (v/v) sodium dodecyl sul fate . 4'% (wi v) sucrose, 4 mM eth ylenedi-
amine tetra aceric acid) , and subjected to sod ium dodecyl sul fate-po lyacry l-
amide gel electropho resis and Western blotting as prev io usly described 
(Burne tte , ·\ 981; Bull d ol. 1994) . T he an ti-e NOS an tiserum w as diluted 
1:1 ,000 in T ris/Tw een buffer (150 mM Tris-H C I, pH 7.5. 150 IllM N aCI. 
0.05% (vlv) T weell 20) and the a lka line phosph:ltase-conjugated goat 
anti-rabbit IgG (Southern Bio techllologies, B irmingham . AL) was dilu ted 
1 :3000 in T rislTween buffer. 
Assessmellt of NO Rele ase from HDMEC IlIhibiti(J 1I "j' Pl l1 teiel Aggrc-
g trliOIl ConAuent m o no layers of H D M EC were tre;lw d with 10 (.LM indo-
m ethacin to block prostaglandin syn thesis and the ll trypsini zed and resus-
pended ill seftlln- free Iscovc's D ulbccco's nl o di ficd Eagle' s 111e djuIll 
conta ining 10 J.LM indo m ethacin at a concentratio n o f 5 X 1 OS I III \. 
In sO llle experiments indo m eth acin-trea ted HDM EC were Exed in 
glu taraldchyde fo r 15 lIlin (0 .25'% (wi v) in PBS) he fo re usc to tcs t w hether 
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J-l D M EC-llledi ated inhib itio n of plate let aggreg;Hio n co uld be attributed 
sole ly to H D MEC/platele t contact. 
Olood was collected fronl do no rs w h o were 11 0 1l-s lllokc rs and wh o had 
taken no m edication fo r at least 2 wks prio r ro phle boromy. N ine volum es 
of hlood wcrc co llected by clean vene puncture in to 1 volume of 3.13% 
(w/v) trisodiu lll c itrate. T he pla te let ri ch p l"s" 1<1 was separated fro m the red 
blood ce ll s by centr ifuga ti o n ( 1 80.~, 'I S mill , 4°C ) and loaded onto 2 Illl or 
I-\i stopaq ue . Aft e r cen trif ugatio n p .SOOX. 20 lIIin . 1 5°C) th e platelets were 
co ll ected fro m the intcrface between the Histopaque and plasm a. The 
platel et pell e t was resuspended in T yrode's btlO'e r (139 111M NaC I, 6.1mM 
KC I. 2.4 m M M gSO., . 7H 20. 3 .1 111M N a2H PO." 6.4 111M N-2-hydro,-,)'-
eth ylpi perazinc- N' -2- e th anes ul fo ni c acid. p H 7.3) con taining 3.1 mM 
g lucosc and 0.3S'Yo. (w/v) bovine se rum albumin. and the count was <1dju sted 
to 1.5 X 10"/m\. Immediately pri o r to each experim ent. the specific cyclic 
GMI' phosphodi esterase inhibitor M &B 22948 (1 00 nM flc) was added to 
each aliquo t of platele ts to poten tiate the "fleet of N O by blocking 
hyd ro lysis o f cyclic GMP (M artin ,.t nl. I 'JH6; R ado m ski ct 111. '1987) . 
Aggregatio n o f wash ed platelets was assessed by t.h e optical impedence 
m cth od (Born and Cross, 1963) . The th romboxane A, analogue U4661 9 
(9, 'f 1-dideoxy-9LY .11 a -llIethanoepoxypros ca g landill F2,, : C ascade Bio-
chemical s. R eading. U .K.) was used as the aggrega ting agen t. T he toral 
volume of th e rC'lcti o n mi x ture was 300 (.LI and consisted o f 200 J.LI of 
platelet sLlspension (1 .5 X 'IO"/ ml) t.o w hich W <lS added 30 fJ.1 of HD MEC 
suspensio n o r Iscovc 's Dulbecco i m odified Eaglc ' s m ediul1l. 30 J.Ll of 
neLlro pepridc o r T yrode's buffer and 30 (.LI of U4CJ619 (100 nM to .\ J.LM) . 
T hese concentra tions of U 46619 induced a clear biphas ic platelet aggrega-
tion respo nse. 
T he ph,telet suspension was equilibrat.ed at 37°C for 5 min, and at t = 
- 30 s an aliq uot of HDM£C was added to th e aggreg;ltion cuverte. At t = 
- \ 5 s. the test ago nist (CGR P o r SP) was added to th e cuve tte, and at time 
t '" 0 platelet aggregatio n was ini tiatcd by th e addi tio n o f the aggregating 
agent U46619. Platele t aggregation w as m o ni rored for 4 min and the 
aggregatio n respo nse was measured as the d iffe rence between the baseline 
li ght transmissio n and the li gh t tr ;lI1 smiss io n atier 4 min (Furl o ng ct nl, 1987: 
R.ado mski ,., nl. \ 987) . 
/11 cxperim cllts w ith hem oglo bill (J-lb). the platele ts W ('rC incubated for 5 
min wi th 5 Il.M Hb prio r to th e additi o n of I-IDM EC o r agonists. I-Ib was 
prepared as described (M artin ct 111. '\ 986 ). 
Nitrite F ormation Confluent m o no layers of l-ID M EC, grown in 24-well 
p lates. we re cultured in H .. PMI 164U w itho ut L-a rginine fo r 2 ~ h prior to 
each experiment. T he cells were th en w ashed w ith serum-frec il. .. PMI 1640 
w itho ut L-a rg in ine Or pheno l red and equilibra ted fo r 30 Illin at 3 rc, 5% 
CO,/95% humidi fi ed air in the sam e culture m edium. At t "" - 30 min. 
L-NM M A (5 111M flc) w as added to 12 we lls in each plate. and L- argi nim· 
(2 111M fl c) was added to the o th er J 2 well s. At I == 0, the d iffe rent agon.isrs 
(CG R.P or SI') were added. T he reaction s were allowed to proceed for 30 
min at 37°C . 5% C02 /9S% humid ified a ir, afte r which time the SU pcflw ralll 
W ilS aspirated and frozen at - 2QoC for ni t ri te a SS;l )'. 
Ni trite was m easured by a Au o ro illetri c II1 cthod (Misko I" 111, J 993). 
Samples (fi'eo of phenol red) were added to acidifi ed 2.3-diaminonaph-
thel ene (Fluka C hemical s, G illingham. U .K.) and le ft fo r 10 min pro rected 
fro m li gh t. Fluorescen t 'I-(H)-l1aph tho tri azo le was detected in a Perkin 
Elmer (Norw:1lk . CT) LS- S spcctro fluo rimete r at 365 nm (excitation) and 
426 nm (emissio ll ) . I' luo rescencc was cnhanced by the "ddi tion ofNaOI-l to 
g ive the sample a pH value of 12 and the va lues rcad against sodium Ilitrit~ 
st;lJI dards of 50 - 300 pillois. 
Data Analysis T he data was analyzed using th e Studen t's t tcst fo r paired 
data. and p < 0.05 was considered to be statisticall y signi fica n t. 
Materials CG R.P was a gift fro m Cell tech , Slo ugh . U .K. and M &B 22948 
was a g ift [roll1 Dr Yvonne Yeung at R.h o lle- i>o ul enc R.o re r. Dagenhal1l, 
U.K. SI' w as purchased fro m Pcninsula Laboratories, St Helens, U. K. and all 
o th er reagell ts 'were purchased fro m Sigll1a. Poole. U .K. unl ess othcrwis~ 
indicatcd ill the text. 
RESULTS 
Immunoreactive eNOS is Detectable in Huma n Neonatal 
F oreskin and Dermal Microvascula r Endothelial Cells The 
bl ood vessels in th e d e rmis were clea rl y ide nti fied w h e n skill 
sectio n s wcre sta i.n c d w it h an an tibo d y aga inst v WF protein. the 
class ic al e ndo theli a l ce lJ marke r (Fig l A ). Immuno r e ac ti ve eNG 
w as d etected in the bloo d v e ssels at a ll levels of th e d e rmis (Fig 1B) 
includin g the c apillary loop s in the d e rma l p apillae (Fig te). 
Compari son of serial secti o n s (Fig lA alld B) sh owed that the 
e N OS stainin g p flttCm in the blood vesse ls cOlTespollde d co t ha t for 
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Figure 1 . IIll1TIUI10rcactivc eNOS is detectable in luunan skin and luicrovascular endothelial cells . Sc rinl secti o n s of neonata l foreskin were 
successivel y sta ined w ith e iri ler rabbi t anti-v\-VF prote in an tiserulIl (II) , rabbi t anri-eN OS antiseru 11I (U, C ), o r ve hide alo ne (D) . fo llowed by b iorin ylared 
goa t an ti-ra bbit IgG and avidin-biotin-co l11l'l ex. T he colo r w as developed w irh DA\3 nsing nickel enhancc lIlc llt as desc ribed in the text, U nstilllubted 
HDMEC (E, C) and C GRJ'-stillllll atcd HDM EC (1'.) were srained with anti-eNOS an tiserum (E, F) or vchi cle alo ne (C). ro ll o wed by bio tinylaterl goa t 
an ti-rabbi t IgG and avidin-hio tin-complex. The co lor was developed with DAU usi ng uickd cnhan CC l11 c llt . Seal" bar. 50 j.,Ull. 
vWF. T he anti-e NOS an tiserum also stained m o nolaye rs o f l111-
stimulated HDMEC (Fig 1D) and HDM EC in cubated w ith CCRP 
fo r 6 h (Fig 1E). eNOS imlllun orea ctiv ity was associated w ith 
intrace llular m embranes and the re was a lso sra ining over th e 
nucleus. T he re was no <l pparellt diffe rence in the st<linin g pattei'll 
between th e un stimul ated and CG RP-stimulated cell s. 
eNOS Protein is Expressed in HDMEC and in the Dermis of 
Neonatal Foreskin but Not in th e E pidermis NOS binds to 
ADP and can be subsequentl y e lu ted with f3-NA DPH (Poll ock c/ nl, 
199 1). T his observation was used to isolate N OS fi 'om HDM EC 
and samples of neonata l dermis and epide rmis. In weste rn blots of 
pro tein extracts prepared fi'o l11 unstimu lated HDMEC and e lu ted 
from ADP- aga rose co lu mns w ith f3-NADPH in H13 co n tain ing 
CHA PS, the anti-eNOS an tise rull1 detccted a band with a mo lec-
ula r weight of approximately 135 kDa (Fig 2, Inll~ A ) and f.1int 
bands w ith m olecu lar weigh ts of approx im ately 60 and 65 kDa. 
T h e 135-kDa band was also dete cted in w es tern b lots of protein 
ex tracts prepared £i'om neona tal dermis (Fig 2, Inll e H) but nor in 
wes tern bl ots of pro tein extracts prepared fi'o l11 ncona ta l ep ide rmis 
(F ig 2. Inllc C). In weste rn blots of HDMEC incuba ted w ith the 
prim ary an tibody diluellt and then with the alkaline phosphatase-
conj ugated second layer an tibody, there were no v isible bands (Fig 
2, l<1/lc D). 
HDMEC Inhibit U46619-Induced l>latelet Aggregation 
U46 619 sti mula ted the aggrega tion of washed human platelets as 
indica ted by an inc rease in li gh t tral1Smiss ion (Fig 3A, a; 3B). T he 
aggregation response w as biphasic. U46619-induced aggregation of 
the washed human platelets was redu ced w hen H DMEC w ere 
added to the p latelet sli spension 30 s bcl'ore addition of the 
A B D 
~205 
~116 
~98 
~66 
~45 
F ig ure 2. eNOS prote in is expressed in HDMEC a nd n eonatal 
der1nis bu t no t n eona ta l cpidcrluis . Protein cx rra c rs prcp:1rcd /1'0111 
I-IDM EC (/ (/I/1 'S ~j , D) . rl erm is (/(/ (/ (' 13). and epide rmis o f no rnl al , ki n (/nllI' C) 
were applied to AD I'-agarosc colulllns. T he AD !' bound pro re ins were 
e lu ted w ith 10 nlM J3-NA DPI-l in H \3 !:omai n in!,: C HAPS. \X/esrcl'II blots of 
th e ADP-agarosc CO lU I11tl elua tes WCfe incuhated w ith a11ti -eNOS antis erulll 
(/n(/I's A, B. C) or di luent bu ffc r a lo ll e (/((//(' D) fo llowed by alkaline 
phosphattl sc-conju garco second laye r :lntiscn1l11. T he co lor was deve lo ped 
with BC IP/ NBT as rlesc ribed in the text. Mo lecular w eigh t lII ark e rs arc 
ind icated 0 11 the ri g-In-hand s id e of the bl o t. 
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Figure 3. HDMEC inhibit U46619-induced platelet aggregation 
and Hb blocks the inhibitory effect of the HDMEC. (A) The platelet 
aggregation response was monitored for 4 min fo llowing addition of 
U46619 to an aliquot of washed human platelets (a). HDMEC at 250 
cells/ IJ.I (b) and 500 cells/ IJ.I (c) were added to the platelet suspension 30 s 
before addition of the U46619 and the aggregation response was monitored. 
Platelets were pre-treated with 5-IJ.M Hb for 5 min prior to addition of the 
HDMEC and the U46619-induced aggregation response was monitored (tI). 
This is a representative tracing of a single experiment that was repeated four 
times using platelets and endothelial cell s from different donors. (B) U46619 
was added to an aliquot of washed human platelets, and the extent of 
platelet aggregation was measured as the change between baseline Hght 
transmission and Hght transmission 4 min after the addition ofU46619 (1i!llI). 
HDMEC were added to the platelet suspension 30 s before addition of 
U46619 and the extent of platelet aggregation was measured (0) . Platelets 
were pre-treated with 5-ILM Hb for 5 min before addition of the HDMEC 
and U46619 and when the extent of platelet aggregation was measnred (0 ). 
The results are expressed as mean ± SEM; n = dupHcate determinations of 
four separate experiments. 
aggregating agent U46619 . This was evident as a reduction in light 
transmission (Fig 3A, band C; 3B) . HDMEC-mediated inhibition 
of U46619-induced platelet aggregation was dependent on the 
HDMEC:platelet ratio. The higher the concentration ofHDMEC, 
the greater the inhibition of U46619-induced platelet aggregation 
and reduction in light transmission. When the platelets were 
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Figure 4. SP potentiates HDMEC-mediated inhibition of platelet 
aggregation. Platelet aggregation was induced by U46619 alone (1i!llI), by 
U466 19 in the presence ofHDMEC (250 ce li S/loLl) (0 ), in the presence of 
SP (10 nM) and HDMEC (250 ce liS/ILl) (.), or in the presence ofSP (1 0 
nM) , HDMEC (250 celis/ ILl), and Hb (5 ILM) (0 ); and the change in light 
transmission was J11casured after 4 1l1in. The results arc expressed as l11can + 
scm; n = duplicate determinations of three separate experiments. 
pretreated with 5 J.LM Hb for 5 mi.n before addition of the HDMEC, 
the inhibitory effect of HDMEC on U46619-induced platelet 
aggregation was blocked as indicated by an increase in light 
transmission (Fig 3A, d; 3B). 
Inhibition of platelet aggregation did no t occur when glutaral-
dehyde-fixed HDMEC were added to the platelet suspension. 
Aggregation induced by U 46619 alone was 33.8 ± 5.4 units 
compared to 27.3 ::':: 4.4 units in the presence of glutaraldehyde-
fixed HDMEC (n = 4 experiments). 
SP Potentiates HDMEC-Mediated Inhibition of Platelet 
Aggregation When SP (10 nM) was added to an aliquot of 
washed human platelets after the addition of the HDMEC, there 
was an increase in the light transmission, indicating that HDMEC-
mediated inhibition of platel et aggregation was potentiated by SP 
(10 nM) (Fig 4) . The combined inhibition of U46619-induced 
aggregation by HDMEC and 10 nM SP was completely reversed 
when the plate lets were pre-treated with 5 J.LM Hb. SP (10 nM) 
alone had not effec t on platelet aggregation . 
CGRP Directly Inhibits U46619-Induccd Platelet Aggrega-
tion When CGRP (100 pM to 100 nM) was added to an aliquot 
of washed human platelets in the absence ofHDMEC there was an 
increase in light transmission indicating that CGRP alone directly 
inhibited U46619-induced platelet aggregation (Fig 5). Concentra-
tions ofCGRP less than 100 pM had no effect on U46619-induced 
platelet aggregation and concentrations greater than 1 fLM were 
cytotoxic as indicated by increased uptake of trypan blue (data not 
shown) . 
CGRP and HDMEC Do Not Interact to Potentiate Inhibi-
tion ofU46619-Induced Platelet Aggregation When a sub-
threshold concentration ofCGRP (10 pM) or low concentrations of 
CGRP that inhibited U46619-induced platelet aggregation (100 
pM to 1 nM) were added to a suspension of washed platelets in the 
presence ofHDMEC, there was no potentiation or synergism of the 
inhibitory effect of either the HDMEC or CGKP (Fig 6) . 
Nitrite Is Released Constitutively from Unstimulated 
HDMEC and CGRP and SP Potentiate Nitrite Release. 
Nitrite was detectable in the supernatant of unstimulated HDMEC 
(Table I) . In monolayers of HDMEC incubated for 30 min with 
either CGRP (100 pM to 10 nM) or SP (100 pM to 1 fLM) there wa 
an increase in nitrite release compared to that from lillstimulated 
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Figure 5. CGRP directly inhibits U46619-induced platelet aggre-
gation. Platelet aggregation W<lS induced by U46619 alone (~) and by 
U46619 in the presence of CG IU) (100 pM - 100 nM) (.). and the change 
in light transmission was measured after 4 min . The results are expressed as 
mean + SEM; n = duplicate determinations of three separate experiments. 
cells. The increase in nitrite re lease was statistically significant in 
HDMEC lllcubated with SP (10 11M and 1 J-lM) and in HDMEC 
incubated with all concentratio ns ofCGRP (100 pM to 1 J-lM). The 
peptide-lllduced increase in Iutl-ite release induced by CGRP (10 
nM) and SP (10 nM) was significantly reduced (p < 0.05) in the 
presence of5 mM L-NMMA compared to release in the presen ce of 
peptide alone. 
DISCUSSION 
NO h as been shown in a se ries of pharmacological studies using 
both anima.! and human vascular preparations to be a potent 
mediator of agonist-induced endothelium-dependent vasodilatation 
(Busse et aI, 1989; Furchgott and Vanhoutte, 1989). In the present 
study, we have demonstrated that eNOS, the constitutive endothe-
lial cell isofonn of NOS , is expressed in the blood vessels through-
out the dermis of neonatal foreskin and in endothelial cells cultured 
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Figure 6. CGRP and HDMEC do not interact to potentiate inhibi-
tion ofU46619-indueed platelet aggregation . Platelet aggregation was 
induced by U46619 alone (1Sl) , by U46619 in the presence of HOMEC (500 
cells/MI) (D), HDMEC (500 cells /).Ll) + CG RP (10 pM) (til), HOMEC 
(500 cells/ ).Ll) + CGIU) ('100 pM) (~) . or HDM EC (500 ce Us/).LI) + CGJUJ 
(10M) (1S::l). The change in light transmission was measured after 4 min. 
The results are expressed as mean + scm; n = duplicate determinations of 
three sepa rare cxpcrinlcnts. 
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Table I. Nitrite Is Released Constitutively From 
HDMEC and CGRP and SP Potentiate Its Release 
IXI Bas~, 1 
Nitrite (M) Release 
Basal 0.66 ± 0.13 100 
Basal + 5 mM L-NMMA 0.69 ± 0.05 105 
Substance P 
100 pM 0.9S ± O.17 144 
10 nM 1.16 ± 0.03 ' 176 
I).LM 1.55 ± 0.26 ' 235 
10 IlM + 5 mM L-NMMA 0.78 ± 0. 14t 118 
CG IU) 
100 pM l. SI ± 0.10t 229 
:1 0 nM 1.37 ± 0.06'1' 209 
1 ).LM 1.32 ± 0.22 ' 201 
10 nM ± 5 111M L- NMMA 0.88 ± 0.04 t 134 
Nitrite levels in the slI pen13tanr ofHDME we re Tllc;\sllrcd as described in rhe text. 
The concentration of nitrite is expressed :1S (he mean j.tM :t SEM nitrite and as a 
percentage of the oas:l l release. 11 = d uplicate determinations from five separate 
experiments in which l Or. ce lls were incub;'ltcd in 200 ,ul orRPM I 1640 without phenol 
red fo r 30 mill wilh SP ;'I nd CGRP at the specifi ed conccntr:lrioIlS . ... p < 0.05. t P < 
0.02. 
from the same blood vessels. Analysis of eNOS in large vessel 
endothelial ce lls has shown that the N-termi.nal of the protein is 
myristoylated, suggesting that the e nzym e is m embrane associated 
(Busconi and Miche l 1993); however, the precise intrace llular 
location of eNOS has not been unequivoca lly established. Density 
gradient centrifugation and analysis with sub-cellular e nzyme 
markers ha s shown that g reater than 95% of the NOS activl!:)1 is 
associated with the microsomal (membrane) fraction (Hccker c/ aI, 
1994). Using immunoelectron microscopy, eNOS has been fo und 
in association with the plasma m embran e and the m embranes of 
intrace llular vesicles in some endothelial cells in the human umbi.l-
ica l vein, and in other cells e lectron dense m aterial has been found 
in the cytoplasm (Pollock cl ai, 1993). T here is no data regarding 
the ultrastructural localiza tion of eNOS in microvasc ular endothe-
li al cells. The immunohistochemical evidence presented he re sug-
gests that the eNOS is associated with intracellular membranes, but 
it is not possible to bc 1110re specific at the light microscope levcl. 
T he re is no difference in the staining pattern between unstimulated 
and CGRP-stimulated cells, which is no t unexpected because 
eNOS js a constitutively expressed en zym e. In the present study we 
have demonstrated that e NOS in HDMEC h as a mol ecular weight 
of approximately 1.35 kDa, which is the same as the protein purified 
from large vessel endotbeljal cells (Pollock c( aI, 1993; Lamas c( nl, 
1992). 
T he results of the biochemical study demonstrate that eNOS is 
functionally active in HDMEC and that N O is re leased both 
constitutively and in response to vasodilator ncuropeptides SP and 
CGRP. Constitutive NO activity was inhibited in the presence of 
Hb, and yet basal Iutrite formation was unaffected by the non-
selective NOS antagonist L-NMMA. The lack ofeffcct of L-NMMA 
on basa l nitrite formation is in agreement w ith the results of the i ll 
lIillo pharmacologica l studies that showed that resting cutaneous 
blood flow was unaltered following intradermal injection of 25 
pmol of L-NMMA (Goldsmith ct aI, in press). 
SP is a classical endotheljum-dependent vasodilator (Furchgott 
and Vanhoutte, 1989) that has been shown to lllduce release of NO 
from cultured bovinc aortic endothelial cel.l s (Smith and Lang, 
1990). SP also increases vascular permeability III a variety of 
vascular beds and in rats; thjs has been related to local production 
of NO (Hughes e( aI, 1990). T he results of the current studies show 
that SP induces releasc of NO from HDMEC. T his suggests that 
NO released 6.'om the microvascular endothe lium may playa role 
in SP-induced vasodilatation , and / or increased vascular permeabil-
ity in human skin. . 
CGRP is one of the most potent vasodilators known (Bram c( nl, 
1985). Investigations have shown that its m echan ism of action can 
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be eith er e nd othelium-dependent, NO-mediated (Gray and Mar-
shall , 1992), or endothelium-independent (Greenberg CI nl, 1987), 
depending on the species and vasc ular bed studied . In hum an skin 
the NOS antagonists , L-NAME and L-NMMA, on ly partially 
reduce the area of erythema and in crease in blood Aow induced by 
an intraderma l injection ofCGRP, suggesting that CGR..P-induced 
vasodilatation is m ediated by NO-dependent m echanisms and also 
by NO-independent mechani sm s. T he results of the present studies 
show that C GRP ca n stimulate release of NO fi'om HDMEC, but 
it can also directly inhibit agonist-induced platelet agg"egation by a 
mechani sm that is not blocked by Hb. T he ability of CGRP to 
directly inhibit platelet aggregation in the absence of endothelial 
cells is in keeping with its known endothelium-independent m ech-
anism of vasorelaxation (Greenberg ci nl, 1987; Edvinsson CI nl, 
1987). T he in ability ofHDMEC to potentiate the partial inhibitory 
e ffec t of low concentrations of CGl~P may be because the direct 
inhibitory action of CGRP on platelet aggregation was so profound 
that any additional inhibitory efFect, m ediated by release of NO 
fi'om HDMEC, w as obscured . Both CGRP-mediated inhibition of 
platelet aggregation and CGRP-induced nitrite formation failed to 
exhibit classica l concentration-dependent responses. T he reasons 
for thi s are uncl ear; howeve r, concentrations of CGRP less th an 
100 pM had no effect on platelet aggregation or nitrite formation, 
and concentrations greater than 1 J-LM were cytotoxic to the 
HDMEC as measured by increased trypan blue exclusio n. 
In these in vestigations, we have identified eNOS. a constituti ve 
isoform of NOS, in the microvascular endothelium in human skin 
and demonstrated that these cells release NO constitutively and in 
response to th e vasodilator neuropeptides CGRJ) and SP. T hese 
data are compatibl e with the idea that NO is involved in the 
mailltenance of "estin g vascu lar tone in the human cutaneous 
microva sculature, and ,in the generation of neurogenic vasodilata-
tion in hum an skin. 
T his ;""1'1< '/Ins slIppor,ed b)' n groll' jim" 'he Henl,h fII,,1 S nj;!I), £-,"e(lllil" ', U.K. 
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